» Articles » PMID: 6182252

Variation of (2'-5') Oligo A Synthetase Level in Lymphocytes and Granulocytes of Patients with Viral Infections and Leukemia

Overview
Publisher Mary Ann Liebert
Date 1982 Jan 1
PMID 6182252
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Using a simplified technique for the determination of oligoisoadenylate synthetase activity, we have compared the cellular level of this interferon (IFN)-induced enzyme in multiple samples of peripheral blood leukocytes. In mononuclear cells (PBMC) of healthy donors the enzyme level was remarkably constant, but in the cells of about 85% of patients with viral infections enzyme activity was significantly elevated. In contrast, the incidence of elevated activity in bacterial infections was low. Synthetase activity could be also detected in granulocytes, although normally its level in these cells was considerably lower than in PBMC. A sharp increase in the enzyme level in granulocytes was found in cells exposed in vitro to IFN, as well as in cells from patients undergoing IFN therapy. Increased synthetase activity was also detected in the granulocytes of patients with viral infections. We have also determined the level of the enzyme in patients with various types of leukemias. In a large proportion of the patients with acute lymphoblastic leukemia (ALL) we found severely decreased enzyme levels (10-20% of control value). The decreased activity could usually be correlated to predominance of blast cells in the peripheral blood.

Citing Articles

Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.

Pawlotsky J, Hovanessian A, Roudot-Thoraval F, Robert N, Bouvier M, Babany G Antimicrob Agents Chemother. 1996; 40(2):320-4.

PMID: 8834873 PMC: 163109. DOI: 10.1128/AAC.40.2.320.


Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine.

Bonnevie-Nielsen V, Heron I, Monath T, Calisher C Clin Diagn Lab Immunol. 1995; 2(3):302-6.

PMID: 7664176 PMC: 170150. DOI: 10.1128/cdli.2.3.302-306.1995.


Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells.

Merlin G, Chebath J, Benech P, Metz R, Revel M Proc Natl Acad Sci U S A. 1983; 80(16):4904-8.

PMID: 6348777 PMC: 384155. DOI: 10.1073/pnas.80.16.4904.


Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.

Ikeda T, Pignatelli M, Lever A, Thomas H Gut. 1986; 27(12):1498-501.

PMID: 3804026 PMC: 1433958. DOI: 10.1136/gut.27.12.1498.